 |
|
|
| |
Drug-Drug Interactions of the Direct Acting Antiviral Regimen of ABT-450/r, Ombitasvir and Dasabuvir with Emtricitabine + Tenofovir, Raltegravir, Rilpivirine and Efavirenz
|
| |
| |
Reported by Jules Levin
ICAAC 2014 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 5-9, 2014, Washington, DC
A. Khatri, T. Wang, H. Wang, T. Podsadecki, R. Trinh, W. Awni, S. Dutta, R. Menon
AbbVie Inc., Research and Development, North Chicago, Illinois 60064, United States
|
| |
|
|
|
|
|
